Patient consent to the use of genetic material in Poland and worldwide

Authors

  • Rafał Patryn Department of Ethics and Human Philosophy, Medical University of Lublin Author
  • Mariusz Goniewicz Emergency Medicine Unit, Medical University of Lublin Author
  • Anna Włoszczak-Szubzda Department of Health Sciences Methods and Statistics, Institute of Rural Health in Lublin Author
  • Krzysztof Goniewicz Emergency Medicine Unit, Medical University of Lublin Author
  • Jarosław Sak Department of Health Sciences Methods and Statistics, Institute of Rural Health in Lublin Author

DOI:

https://doi.org/10.12923/j.0044-2011/122-4/a.20

Keywords:

declaration of intent, genetic material, patient’s consent, health policy

Abstract

Currently developed and functioning models of so-called informed consent seem to be insufficient in case of the application, handling, or use of the genetic material, and may lead to over-interpretation or misinterpretation of the formal rules for using the stored genetic material. In medical practice, the aim is to obtain patient’s consent to any interventions not only therapeutic, but also other, having a diagnostic character. These interventions often lacking direct medicinal goal, are often associated with a high risk to the health of the patient, who should be informed about that. The most common form of consent is called informed consent, in which the emphasis is primarily put on the patient’s understanding of what needs to be signed on a specific form. The informed consent is a fundamental element of the subjective permission to submit to any intervention that interferes in bodily-mental realm of man. Currently valid provisions contained in a number of non-synchronized with each other regulatory acts selectively treat the concept of informed consent in the case of working with genetic material (the use, processing) and its terminal (temporary) use. The issue of storing genetic material in biobanks (both worldwide and in Poland) does not have a leading and promoting solution, and the present standards specifying the type and nature of consent are rather formal parts of different formal acts than a single standardized model. There is a need to have a new uniform interpretation of the law, which could be the basis for the concept of consent as a declaration of intent for the use of genetic material.
The report presents a formal-legal approach to the issue of the concept and scope of consent as a declaration of intent, in the case of genetic material use. The currently existing in Poland and in the world legal solutions of the interpretations of the concept and scope of consent, as a declaration of intent for the use of genetic material, have been analyzed. The actual and hypothetical disputable and interpretation issues have been discussed. The paper presents original solution clarifying the issues of informed consent, which can be used in practice.

References

1. Convention for the protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. European Treaty Series (ETS) Nr 164. Oviedo. 4.IV.1997.

2. WMA Declaration of Madrid on Professional Autonomy and Self-Regulation. Adopted by the 39th World Medical Assembly Madrid, Spain. October 1987.

3. Art. 16 Ustawy z dnia 6 listopada 2008 r. O prawach pacjenta i Rzeczniku Praw Pacjenta. (Dz. U. z dnia 31 marca 2009 r. Nr. 52, poz. 417).

4. Ustawa z dnia 5 grudnia 1996 r. O zawodach lekarza i dentysty. (Dz. U. z 2005 r. Nr 226, poz. 1943).

5. Ustawa z dnia z dnia 30 sierpnia 1991 r. O zakładach opieki zdrowotnej. (Dz. U. 1991 nr 91, poz. 408).

6. Rozporządzenie Ministra Zdrowia z dnia 2 października 2006 r. w sprawie wymagań Dobrej Praktyki Klinicznej (Dz. U. Nr 194, poz. 1436).

7. Ustawa z dnia 23 kwietnia 1964 r. – Kodeks cywilny (Dz. U. z 1964 r. Nr 16, poz. 93).

8. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 4th ed. New York: Oxford University Press; 1994.

9. Wyrok SN z dnia 25 marca 1981 r. (11 CR 74/81).

10. Szczygieł G, Bagan-Kurluta K. Pricnciple of respecting medical confidentionality and protection of interests of third parties in association with threat to their health and life AIDS/HIV. Law and Medicine. 2004;3:16-6.

11. Nestorowicz M. Medical law. Torun: TNOIK; 2005.

12. Atras A, Patryn R, Marczewski K. Problems related with obtaining informed consent in opinions of students of the Medical University. Pielęgniarstwo XXI. 2006;1:11-25.

13. Niemczyk S, Łazarska A. Material and legal elements of declaration of patient consent from the legal and medical aspects. Law and Medicine. 2005;5:19-48.

14. Etchells E, Gilbert BA. Bioethics for clinicians: 1. Consent. Canadian Med Assoc J. 1996;155:1083-16.

15. Ahronhein JC, Moreno J. Ethics in clinical practice. Boston: Brown and Co; 1994.

16. Annas GJ. A national bill of patients’ rights. New Engl J Med. 1998;338(10):695-9.

17. Pawlikowski J, Sak J, Marczewski K. Biobank research and ethics: the problem of informed consent in biobanks. Arch Med Sci. 2011;7(5): 896-901.

Downloads

Published

2012-12-01

How to Cite

Patryn, R., Goniewicz, M., Włoszczak-Szubzda, A., Goniewicz, K., & Sak, J. (2012). Patient consent to the use of genetic material in Poland and worldwide. Polish Journal of Public Health, 122(4), 440-445. https://doi.org/10.12923/j.0044-2011/122-4/a.20